Joanne Lagmay, MD : Research

The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been approved by the U.S. Food & Drug Administration (FDA), or any other…

Investigator

Joanne Lagmay

Status

Accepting Candidates

Ages

N/A - 26 Years

Sexes

All

This single arm study is designed to demonstrate the feasibility of a radically different approach for an exceptionally high-risk subset of MES with widely metastatic disease (WMES). We incorporate the use of evolutionary principles that apply to…

Investigator

Joanne Lagmay

Status

Accepting Candidates

Ages

1 Year - N/A

Sexes

All

The purpose of this study is to evaluate the investigational drug, silmitasertib (a pill taken by mouth), in combination with FDA approved drugs for solid tumors. An investigational drug is one that has not been approved by the U.S. Food & Drug…

Investigator

Joanne Lagmay

Status

Accepting Candidates

Ages

N/A - 30 Years

Sexes

All